BACKGROUND: Adipose tissue is significantly involved in inflammatory bowel disease (IBD). Vitamin D can affect both adipogenesis and inflammation. The aim of this study was to compare the production of selected adipokines, potentially involved in the pathogenesis of IBD - adiponectin, resistin, retinol binding protein 4 (RBP-4), adipocyte fatty acid binding protein and nesfatin-1 in children with IBD according to the presence of 25-hydroxyvitamin D (25(OH)D) deficiency. METHODS: The study was conducted as a case-control study in pediatric patients with IBD and healthy children of the same sex and age. In addition to adipokines and 25(OH)D, anthropometric parameters, markers of inflammation and disease activity were assessed in all participants. RESULTS: Children with IBD had significantly higher resistin levels regardless of 25(OH)D levels. IBD patients with 25(OH)D deficiency only had significantly lower RBP-4 compared to healthy controls and also compared to IBD patients without 25(OH)D deficiency. No other significant differences in adipokines were found in children with IBD with or without 25(OH)D deficiency. 25(OH)D levels in IBD patients corelated with RBP-4 only, and did not correlate with other adipokines. CONCLUSIONS: Whether the lower RBP-4 levels in the 25(OH)D-deficient group of IBD patients directly reflect vitamin D deficiency remains uncertain. The production of other adipokines does not appear to be directly related to vitamin D deficiency.

3rd Department of Internal Medicine Nephrology Rheumatology and Endocrinology University Hospital Olomouc Faculty of Medicine and Dentistry Palacky University Olomouc Olomouc Czech Republic

Department of Clinical Biochemistry University Hospital Olomouc Olomouc Czech Republic

Department of Computer Science Faculty of Electrical Engineering and Computer Science VSB Technical University of Ostrava Ostrava Poruba Czech Republic

Department of Pediatrics University Hospital Olomouc Faculty of Medicine and Dentistry Palacky University Olomouc Olomouc Czech Republic

Zobrazit více v PubMed

Bousvaros A. Use of immunomodulators and biologic therapies in children with inflammatory bowel disease. Expert Rev Clin Immunol. 2010;6(4):659–66. doi: 10.1586/eci.10.46. PubMed DOI

Ruel J, Ruane D, Mehandru S, Gower-Rousseau C, Colombel JF. IBD across the age spectrum—is it the same disease? Nat Rev Gastroenterol Hepatol. 2014;11(2):88–98. doi: 10.1038/nrgastro.2013.240. PubMed DOI

Gonçalves P, Magro F, Martel F. Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel. Inflamm Bowel Dis. 2015;21(2):453–67. doi: 10.1097/MIB.0000000000000209. PubMed DOI

Karaskova E, Velganova-Veghova M, Geryk M, Foltenova H, Kucerova V, Karasek D. Role of adipose tissue in inflammatory bowel disease. Int J Mol Sci. 2021;22(8):4226. doi: 10.3390/ijms22084226. PubMed DOI PMC

Gubatan J, Moss AC. Vitamin D in inflammatory bowel disease: more than just a supplement. Curr Opin Gastroenterol. 2018;34(4):217–25. doi: 10.1097/MOG.0000000000000449. PubMed DOI

Yoon JY. Nutritional approach as therapeutic manipulation in inflammatory bowel disease. Intest Res. 2019;17(4):463–75. doi: 10.5217/ir.2019.00078. PubMed DOI PMC

Rigterink T, Appleton L, Day AS. Vitamin D therapy in children with inflammatory bowel disease: a systematic review. World J Clin Pediatr. 2019;8(1):1–14. doi: 10.5409/wjcp.v8.i1.1. PubMed DOI PMC

Meeker S, Seamons A, Maggio-Price L, Paik J. Protective links between vitamin D, inflammatory bowel disease and colon cancer. World J Gastroenterol. 2016;22(3):933–48. doi: 10.3748/wjg.v22.i3.933. PubMed DOI PMC

Leskovar D, Meštrović T, Barešić A, Kraljević I, Panek M, Čipčić Paljetak H, et al. The role of vitamin D in inflammatory bowel disease - assessing therapeutic and preventive potential of supplementation and food fortification. Food Technol Biotechnol. 2018;56(4):455–63. doi: 10.17113/ftb.56.04.18.5805. PubMed DOI PMC

Del Pinto R, Pietropaoli D, Chandar AK, Ferri C, Cominelli F. Association between inflammatory bowel disease and vitamin D deficiency: a systematic review and meta-analysis. Inflamm Bowel Dis. 2015;21(11):2708–17. doi: 10.1097/MIB.0000000000000546. PubMed DOI PMC

Fatahi S, Alyahyawi N, Albadawi N, Mardali F, Dara N, Sohouli MH, et al. The association between vitamin D status and inflammatory bowel disease among children and adolescents: a systematic review and meta-analysis. Front Nutr. 2023;9:1007725. doi: 10.3389/fnut.2022.1007725. PubMed DOI PMC

Sun YH, Tian DD, Zhou JM, Ye Q. Association between vitamin D level and pediatric inflammatory bowel disease: a systematic review and meta-analysis. Front Pediatr. 2023;11:1155004. doi: 10.3389/fped.2023.1155004. PubMed DOI PMC

Veit LE, Maranda L, Fong J, Nwosu BU. The vitamin D status in inflammatory bowel disease. PLoS ONE. 2014;9(7):e101583. doi: 10.1371/journal.pone.0101583. PubMed DOI PMC

Szymczak-Pajor I, Miazek K, Selmi A, Balcerczyk A, Śliwińska A. The Action of Vitamin D in adipose tissue: is there the link between vitamin D Deficiency and Adipose tissue-related metabolic disorders? Int J Mol Sci. 2022;23(2):956. doi: 10.3390/ijms23020956. PubMed DOI PMC

Weidinger C, Ziegler JF, Letizia M, Schmidt F, Siegmund B. Adipokines and their role in intestinal inflammation. Front Immunol. 2018;9:1974. doi: 10.3389/fimmu.2018.01974. PubMed DOI PMC

Karaskova E, Kubickova V, Velganova-Veghova M, Geryk M, Foltenova H, Karasek D. Circulating levels of WISP-1 (Wnt1-inducible signaling pathway protein 1) and other selected adipokines in children with inflammatory bowel disease. Physiol Res. 2022;71(2):275–84. PubMed PMC

Valentini L, Wirth EK, Schweizer U, Hengstermann S, Schaper L, Koernicke T, et al. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Nutrition. 2009;25(2):172–81. doi: 10.1016/j.nut.2008.07.020. PubMed DOI

Roma E, Krini M, Hantzi E, Sakka S, Panayiotou I, Margeli A, Papassotiriou I, Kanaka-Gantenbein C. Retinol binding protein 4 in children with inflammatory bowel disease: a negative correlation with the disease activity. Hippokratia. 2012;16(4):360–5. PubMed PMC

Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Kouroumalis EA. The effect of infliximab on circulating levels of leptin, adiponectin and resistin in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2007;19(9):789–94. doi: 10.1097/MEG.0b013e3282202bca. PubMed DOI

Beyaz Ş, Akbal E. Increased serum nesfatin-1 levels in patients with inflammatory bowel diseases. Postgrad Med J. 2022;98(1160):446–9. doi: 10.1136/postgradmedj-2020-139227. PubMed DOI

Morshedzadeh N, Rahimlou M, Asadzadeh Aghdaei H, Shahrokh S, Reza Zali M, Mirmiran P. Association between adipokines levels with inflammatory bowel disease (IBD): systematic reviews. Dig Dis Sci. 2017;62(12):3280–6. doi: 10.1007/s10620-017-4806-5. PubMed DOI

Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, et al. European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58(6):795–806. doi: 10.1097/MPG.0000000000000239. PubMed DOI

Hyams J, Markowitz J, Otley A, Rosh J, Mack D, Bousvaros A, Pediatric Inflammatory Bowel Disease Collaborative Research Group et al. Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr. 2005;41(4):416–21. doi: 10.1097/01.mpg.0000183350.46795.42. PubMed DOI

Sempos CT, Heijboer AC, Bikle DD, Bollerslev J, Bouillon R, Brannon PM et al. Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D. Br J Clin Pharmacol. 2018;84(10):2194–2207. PubMed PMC

Turner D, Hyams J, Markowitz J, Lerer T, Mack DR, Evans J, et al. Pediatric IBD Collaborative Research Group. Appraisal of the pediatric ulcerative colitis activity index (PUCAI) Inflamm Bowel Dis. 2009;15(8):1218–23. doi: 10.1002/ibd.20867. PubMed DOI

Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81. doi: 10.1056/NEJMra070553. PubMed DOI

Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008;122(2):398–417. doi: 10.1542/peds.2007-1894. PubMed DOI

Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T, Kouroumalis EA. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12(2):100–5. doi: 10.1097/01.MIB.0000200345.38837.46. PubMed DOI

Konrad A, Lehrke M, Schachinger V, Seibold F, Stark R, Ochsenkühn T, et al. Resistin is an inflammatory marker of inflammatory bowel disease in humans. Eur J Gastroenterol Hepatol. 2007;19(12):1070–4. doi: 10.1097/MEG.0b013e3282f16251. PubMed DOI

Louis Sam Titus ASC, Vanarsa K, Soomro S, Patel A, Prince J, Kugathasan S, et al. Resistin, Elastase, and Lactoferrin as potential plasma biomarkers of Pediatric Inflammatory Bowel Disease based on Comprehensive Proteomic screens. Mol Cell Proteom. 2023;22(2):100487. doi: 10.1016/j.mcpro.2022.100487. PubMed DOI PMC

Boström EA, Tarkowski A, Bokarewa M. Resistin is stored in neutrophil granules being released upon challenge with inflammatory stimuli. Biochim Biophys Acta. 2009;1793(12):1894–900. doi: 10.1016/j.bbamcr.2009.09.008. PubMed DOI

Stokić E, Kupusinac A, Tomic-Naglic D, Smiljenic D, Kovacev-Zavisic B, Srdic-Galic B, et al. Vitamin D and dysfunctional adipose tissue in obesity. Angiology. 2015;66(7):613–8. doi: 10.1177/0003319714543512. PubMed DOI

Tariq S, Tariq S, Khaliq S, Baig M, Murad MA, Lone KP. Association between Vitamin D and resistin in postmenopausal females with altered Bone Health. Front Endocrinol (Lausanne) 2021;11:615440. doi: 10.3389/fendo.2020.615440. PubMed DOI PMC

Vilarrasa N, Vendrell J, Maravall J, Elío I, Solano E, San José P, et al. Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine. 2010;38(2):235–42. doi: 10.1007/s12020-010-9379-4. PubMed DOI

Roth CL, Elfers C, Kratz M, Hoofnagle AN. Vitamin d deficiency in obese children and its relationship to insulin resistance and adipokines. J Obes. 2011;2011:495101. doi: 10.1155/2011/495101. PubMed DOI PMC

Steinhoff JS, Lass A, Schupp M. Biological functions of RBP4 and its relevance for Human diseases. Front Physiol. 2021;12:659977. doi: 10.3389/fphys.2021.659977. PubMed DOI PMC

Metheniti D, Sakka S, Dracopoulou M, Margeli A, Papassotiriou I, Kanaka-Gantenbein C, et al. Decreased circulating 25-(OH) vitamin D concentrations in obese female children and adolescents: positive associations with Retinol binding Protein-4 and Neutrophil Gelatinase-associated Lipocalin. Horm (Athens) 2013;12(3):397–404. doi: 10.1007/BF03401305. PubMed DOI

Rodrigues VS, Milanski M, Fagundes JJ, Torsoni AS, Ayrizono ML, Nunez CE, et al. Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn’s disease. Clin Exp Immunol. 2012;170(3):358–64. doi: 10.1111/j.1365-2249.2012.04660.x. PubMed DOI PMC

Kahraman R, Calhan T, Sahin A, Ozdil K, Caliskan Z, Bireller ES, et al. Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease? Ther Clin Risk Manag. 2017;13:1295–301. doi: 10.2147/TCRM.S140618. PubMed DOI PMC

Weigert J, Obermeier F, Neumeier M, Wanninger J, Filarsky M, Bauer S, et al. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn’s disease. Inflamm Bowel Dis. 2010;16(4):630–7. doi: 10.1002/ibd.21091. PubMed DOI

Waluga M, Hartleb M, Boryczka G, Kukla M, Zwirska-Korczala K. Serum adipokines in inflammatory bowel disease. World J Gastroenterol. 2014;20(22):6912–7. doi: 10.3748/wjg.v20.i22.6912. PubMed DOI PMC

Chouliaras G, Panayotou I, Margoni D, Mantzou E, Pervanidou P, Manios Y, et al. Circulating leptin and adiponectin and their relation to glucose metabolism in children with Crohn’s disease and ulcerative colitis. Pediatr Res. 2013;74(4):420–6. doi: 10.1038/pr.2013.114. PubMed DOI

Ortega Moreno L, Sanz-Garcia A, de la Fernández MJ, Arroyo Solera R, Fernández-Tomé S, Marin AC, et al. Serum adipokines as non-invasive biomarkers in Crohn’s disease. Sci Rep. 2020;10(1):18027. doi: 10.1038/s41598-020-74999-6. PubMed DOI PMC

Walker GE, Ricotti R, Roccio M, Moia S, Bellone S, Prodam F, et al. Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeric adiponectin as a key link between these conditions. PLoS ONE. 2014;9(1):e83685. doi: 10.1371/journal.pone.0083685. PubMed DOI PMC

Bidulescu A, Morris AA, Stoyanova N, Meng YX, Vaccarino V, Quyyumi AA, et al. Association between Vitamin D and Adiponectin and its relationship with body Mass Index: the META-Health study. Front Public Health. 2014;2:193. doi: 10.3389/fpubh.2014.00193. PubMed DOI PMC

Vaidya A, Williams JS, Forman JP. The independent association between 25-hydroxyvitamin D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS. Obes (Silver Spring) 2012;20(1):186–91. doi: 10.1038/oby.2011.210. PubMed DOI PMC

Husemoen LL, Skaaby T, Martinussen T, Jørgensen T, Thuesen BH, Kistorp C, et al. Investigating the causal effect of vitamin D on serum adiponectin using a mendelian randomization approach. Eur J Clin Nutr. 2014;68(2):189–95. doi: 10.1038/ejcn.2013.233. PubMed DOI

Parikh S, Guo DH, Pollock NK, Petty K, Bhagatwala J, Gutin B, et al. Circulating 25-hydroxyvitamin D concentrations are correlated with cardiometabolic risk among American black and white adolescents living in a year-round sunny climate. Diabetes Care. 2012;35(5):1133–8. doi: 10.2337/dc11-1944. PubMed DOI PMC

Carvalho-Rassbach M, Alvarez-Leite JI, de Fátima Haueisen Sander Diniz M. is the association between vitamin D, adiponectin, and insulin resistance present in normal weight or obese? A pilot study. Clin Nutr Exp. 2019;23:80–8. doi: 10.1016/j.yclnex.2018.10.004. DOI

Wright OR, Hickman IJ, Petchey WG, Sullivan CM, Ong C, Rose FJ, et al. The effect of 25-hydroxyvitamin D on insulin sensitivity in obesity: is it mediated via adiponectin? Can J Physiol Pharmacol. 2013;91(6):496–501. doi: 10.1139/cjpp-2012-0436. PubMed DOI

Özkan B, Döneray H, Keskin H. The effect of vitamin D treatment on serum adiponectin levels in children with vitamin D deficiency rickets. J Clin Res Pediatr Endocrinol. 2009;1(6):262–5. doi: 10.4274/jcrpe.v1i6.262. PubMed DOI PMC

Nikooyeh B, Neyestani TR. Can vitamin D be considered an adiponectin secretagogue? A systematic review and meta-analysis. J Steroid Biochem Mol Biol. 2021;212:105925. doi: 10.1016/j.jsbmb.2021.105925. PubMed DOI